Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $20.8300 (0.34%) ($20.2100 - $21.1800) on Tue. Jun. 4, 2019. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.45% (three month average) | RSI | 41 | Latest Price | $20.8300(0.34%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -0.6% a day on average for past five trading days. | Weekly Trend | EDIT declines -3.5% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) IBB(63%) ARKG(60%) XBI(59%) IWO(58%) ARKK(56%) | Factors Impacting EDIT price | EDIT will decline at least -1.725% in a week (0% probabilities). VXX(-17%) UUP(-6%) IFRA(-4%) TLT(-3%) SHY(-3%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.725% (StdDev 3.45%) | Hourly BBV | 0 () | Intraday Trend | -0.9% | | | |
|
1 - 5 Day Possible Target | $9.6(-53.91%) | Resistance Level | $22.28 | 5 Day Moving Average | $20.9(-0.33%) | 10 Day Moving Average | $21.35(-2.44%) | 20 Day Moving Average | $22.28(-6.51%) | To recent high | -25% | To recent low | 1.4% | Market Cap | $1.294b | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |